All In MedTech

FDA Clearance Tracker · P200036-S010

eCoin Peripheral Neurostimulator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 3, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 3, 2026

Approved

Time to decision

29 days

Received Feb 2, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P200036-S010
Device name
eCoin Peripheral Neurostimulator
Applicant location
Marlborough, MA
Received
Feb 2, 2026
Decided
Mar 3, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P200036

Device type

Device class
Class III

Every decision under product code QPT

FDA's approval statement

As written in FDA's record.

Approval for protocol revisions which clarified the definition of subject enrollment and updates to the Schedule of Activities table regarding follow-up phone calls and clarification of protocol-unrelated standards of clinical care.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.